rs34859055
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Uncertain significance. The variant received 0 ACMG points: 0P and 0B.
The NM_177924.5(ASAH1):c.216+46_216+47insTGT variant causes a intron change involving the alteration of a non-conserved nucleotide. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: not found (cov: 0)
Exomes 𝑓: 0.0000012 ( 0 hom. )
Consequence
ASAH1
NM_177924.5 intron
NM_177924.5 intron
Scores
Not classified
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -0.469
Publications
0 publications found
Genes affected
ASAH1 (HGNC:735): (N-acylsphingosine amidohydrolase 1) This gene encodes a member of the acid ceramidase family of proteins. Alternative splicing results in multiple transcript variants, at least one of which encodes a preproprotein that is proteolytically processed. Processing of this preproprotein generates alpha and beta subunits that heterodimerize to form the mature lysosomal enzyme, which catalyzes the degradation of ceramide into sphingosine and free fatty acid. This enzyme is overexpressed in multiple human cancers and may play a role in cancer progression. Mutations in this gene are associated with the lysosomal storage disorder, Farber lipogranulomatosis, and a neuromuscular disorder, spinal muscular atrophy with progressive myoclonic epilepsy. [provided by RefSeq, Oct 2015]
ASAH1 Gene-Disease associations (from GenCC):
- ASAH1-related sphingolipidosisInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- Farber lipogranulomatosisInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Orphanet, Labcorp Genetics (formerly Invitae), Genomics England PanelApp
- spinal muscular atrophy-progressive myoclonic epilepsy syndromeInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Genomics England PanelApp, G2P
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Uncertain_significance. The variant received 0 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 0
GnomAD3 genomes
Cov.:
0
GnomAD4 exome AF: 0.00000116 AC: 1AN: 863340Hom.: 0 Cov.: 12 AF XY: 0.00 AC XY: 0AN XY: 431872 show subpopulations
GnomAD4 exome
AF:
AC:
1
AN:
863340
Hom.:
Cov.:
12
AF XY:
AC XY:
0
AN XY:
431872
show subpopulations
African (AFR)
AF:
AC:
1
AN:
18870
American (AMR)
AF:
AC:
0
AN:
13800
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
15414
East Asian (EAS)
AF:
AC:
0
AN:
26906
South Asian (SAS)
AF:
AC:
0
AN:
32774
European-Finnish (FIN)
AF:
AC:
0
AN:
28284
Middle Eastern (MID)
AF:
AC:
0
AN:
2508
European-Non Finnish (NFE)
AF:
AC:
0
AN:
689450
Other (OTH)
AF:
AC:
0
AN:
35334
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.525
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome Cov.: 0
GnomAD4 genome
Cov.:
0
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
PhyloP100
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.